Published in J Virol on January 01, 1993
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res (2011) 3.81
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol (1997) 1.45
Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol (1995) 1.40
The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J Virol (1999) 1.38
Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J Virol (1999) 1.30
KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells. J Exp Med (2011) 1.28
Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol (2010) 1.13
Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J Virol (1998) 0.96
hsp72, a host determinant of measles virus neurovirulence. J Virol (2006) 0.94
CD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats. J Virol (1997) 0.92
Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding. PLoS One (2014) 0.88
Major histocompatibility complex haplotype determines hsp70-dependent protection against measles virus neurovirulence. J Virol (2009) 0.82
Virus-heat shock protein interaction and a novel axis for innate antiviral immunity. Cells (2012) 0.80
Foxp3+ regulatory T cells control persistence of viral CNS infection. PLoS One (2012) 0.79
Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A (1987) 14.24
Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol (1989) 8.84
Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med (1983) 6.97
Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature (1990) 6.59
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (1990) 6.23
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature (1987) 4.66
Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature (1990) 4.59
Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature (1986) 4.01
An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell (1985) 3.88
A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature (1991) 3.87
Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature (1990) 3.32
Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol (1987) 3.16
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med (1988) 2.85
Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65
Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med (1988) 2.52
Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science (1991) 2.51
Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med (1991) 2.33
Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol (1984) 2.21
Cytotoxic T cells in the lungs of mice infected with an influenza A virus. Scand J Immunol (1978) 2.13
Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature (1991) 2.11
N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J Virol (1986) 2.01
Peptide selection by MHC class I molecules. Nature (1991) 2.01
Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J Virol (1991) 1.96
Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol (1986) 1.84
The role of beta 2-microglobulin in peptide binding by class I molecules. Science (1990) 1.80
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci U S A (1987) 1.77
Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell (1989) 1.64
Recovery from acute virus infection. Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice. Ann N Y Acad Sci (1988) 1.62
The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection. J Virol (1990) 1.57
Altered ratios of measles virus transcripts in diseased human brains. Virology (1987) 1.55
Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science (1987) 1.42
The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis (1987) 1.37
Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway. Immunol Today (1991) 1.37
Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes. J Immunol (1988) 1.35
Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk. J Immunol (1982) 1.33
Measles virus nucleocapsid protein protects rats from encephalitis. J Virol (1991) 1.33
Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. J Immunol (1989) 1.29
Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry? Immunol Today (1989) 1.28
Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J Gen Virol (1986) 1.27
Virological aspects of measles virus-induced encephalomyelitis in Lewis and BN rats. J Gen Virol (1987) 1.26
Cytotoxic T cells in influenza infection. Ann N Y Acad Sci (1988) 1.25
Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T cells. Eur J Immunol (1991) 1.08
Induction of autoimmune reactions to myelin basic protein in measles virus encephalitis in Lewis rats. J Neuroimmunol (1988) 0.97
Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis. J Gen Virol (1991) 0.94
CTL recognition of adenovirus-transformed cells infected with influenza virus: lysis by anti-influenza CTL parallels adenovirus-12-induced suppression of class I MHC molecules. Virology (1988) 0.92
Antigen presentation in virus infection. Curr Opin Immunol (1992) 0.88
Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell (1988) 4.90
Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A (1991) 4.07
The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol (1982) 3.12
Genomic RNA of the murine coronavirus JHM. J Gen Virol (1978) 2.78
Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67
Coronavirus JHM: cell-free synthesis of structural protein p60. J Virol (1980) 2.37
The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci U S A (1991) 2.23
Coronavirus JHM: intracellular protein synthesis. J Gen Virol (1981) 2.05
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology (2000) 2.02
Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol (1997) 2.00
CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol (2001) 1.94
Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A (1995) 1.89
Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A (1996) 1.89
Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A (1997) 1.85
Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol (1986) 1.84
Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology (1989) 1.82
Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J Virol (2000) 1.74
Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1987) 1.68
Infectious DNA of the human spumaretrovirus. Nucleic Acids Res (1990) 1.67
Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol (1998) 1.63
Comparison of subacute sclerosing panencephalitis and measles viruses: an electron microscope study. J Virol (1971) 1.61
Temporal and geographical distribution of measles virus genotypes. J Gen Virol (1995) 1.61
Identification of the major immunogenic structural proteins of human foamy virus. J Gen Virol (1990) 1.60
Differential downregulation of CD46 by measles virus strains. J Virol (1995) 1.57
Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology (1996) 1.56
Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus. Lancet (1972) 1.55
Altered ratios of measles virus transcripts in diseased human brains. Virology (1987) 1.55
Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique. J Gen Virol (1983) 1.50
Membrane proteins of subacute sclerosing panencephalitis and measles viruses. Nature (1978) 1.49
Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J Virol (1985) 1.48
Physical association of moesin and CD46 as a receptor complex for measles virus. J Virol (1995) 1.48
Viral particles induce Ia antigen expression on astrocytes. Nature (1986) 1.46
Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol (1997) 1.45
Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology (1994) 1.44
Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J Virol (1994) 1.43
MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol (1993) 1.43
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
Clonal expansion of hypermutated measles virus in a SSPE brain. Virology (1993) 1.42
Subacute sclerosing panencephalitis: a review. Curr Top Microbiol Immunol (1972) 1.41
The structure and replication of coronaviruses. Curr Top Microbiol Immunol (1982) 1.40
Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol (1995) 1.40
Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology (1992) 1.39
Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci (1994) 1.39
The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J Virol (1999) 1.38
Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat Med (2001) 1.38
Structural polypeptides of the murine coronavirus JHM. J Gen Virol (1979) 1.37
Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature (1983) 1.36
Antibody-induced restriction of viral gene expression in measles encephalitis in rats. J Virol (1990) 1.36
Identification of several different lineages of measles virus. J Gen Virol (1991) 1.35
Isolation of infectious measles virus in measles encephalitis. Lancet (1972) 1.35
Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol (1994) 1.34
Measles virus nucleocapsid protein protects rats from encephalitis. J Virol (1991) 1.33
Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta Neuropathol (1978) 1.32
Morphogenesis and structure of a virus in cells cultured from brain tissue from two cases of multiple sclerosis. Lab Invest (1973) 1.31
Transacting transcriptional activation of human spumaretrovirus LTR in infected cells. Virology (1990) 1.30
Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J Gen Virol (1986) 1.27
Detection of polyoma virus DNA in PML-brain tissue by (in situ) hybridization. J Gen Virol (1979) 1.27
Virological aspects of measles virus-induced encephalomyelitis in Lewis and BN rats. J Gen Virol (1987) 1.26
Demonstration of HLA restricted killer cells in patients with acute measles. Med Microbiol Immunol (1979) 1.26
CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol (1997) 1.26
Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur J Immunol (1995) 1.25
A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol (1999) 1.25
Measles virus induced immunosuppression: targets and effector mechanisms. Curr Mol Med (2001) 1.25
Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line. Nature (1983) 1.25
Progressive multifocal leucoencephalopathy: detection of papovavirus JC in kidney tissue. J Med Virol (1983) 1.24
Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE. J Immunol (1975) 1.22
Measles virus gene expression in subacute sclerosing panencephalitis. Virus Res (1984) 1.22
Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. J Virol (1996) 1.19
Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc Natl Acad Sci U S A (1987) 1.18
Electron microscopic observations in subacute sclerosing panencephalitis brain cell cultures: their correlation with cytochemical and immunocytological findings. J Virol (1970) 1.17
Measles virus persistency and disease. Prog Med Virol (1984) 1.16
Multiple sclerosis and parainfluenza 1 virus. History of the isolation of the virus and expression of phenotypic differences between the isolated virus and Sendai virus. J Neurol (1975) 1.15
Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion. J Virol (2000) 1.14
Human immunodeficiency virus infection in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol (1992) 1.14
Dendritic cells and measles virus infection. Curr Top Microbiol Immunol (2003) 1.14
Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake. J Virol (1999) 1.14
Restriction of measles virus gene expression in acute and subacute encephalitis of Lewis rats. Virology (1989) 1.13
Differential receptor usage by measles virus strains. J Gen Virol (1998) 1.13
RD cells in the laboratory diagnosis of enteroviruses. Med Microbiol Immunol (1977) 1.13
Demyelinating encephalomyelitis induced by a long-term corona virus infection in rats. A preliminary report. Acta Neuropathol (1979) 1.12
RNA-dependent RNA polymerase activity in murine coronavirus-infected cells. J Gen Virol (1983) 1.12
Adaptation of coronavirus JHM to persistent infection of murine sac(-) cells. J Gen Virol (1984) 1.10
Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides. Proc Natl Acad Sci U S A (1979) 1.09
Relationships between monoclonal antibody-binding sites on the measles virus haemagglutinin. J Gen Virol (1982) 1.09
Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro. J Gen Virol (1997) 1.08
RNA homology between subacute sclerosing panencephalitis and measles viruses. Nature (1976) 1.07
CD4+ T cells control measles virus infection of the central nervous system. Immunology (1992) 1.06
The haemagglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro. J Gen Virol (2001) 1.06